FDA Approved: ATOMOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for atomoxetine by Teva Pharmaceuticals USA, Inc., indicating an updated labeling for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

SUPPL AP for ATOMOXETINE (ATOMOXETINE)